Voce criticizes Solta as it attempts to force sale
This article was originally published in Clinica
Executive Summary
Activist shareholder Voce Capital Management has openly blasted aesthetic device specialist Solta Medical and the company’s chief executive, as it piles on pressure for the firm to sell up.